Cargando…

How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa

BACKGROUND: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experime...

Descripción completa

Detalles Bibliográficos
Autores principales: Terris-Prestholt, Fern, Hanson, Kara, MacPhail, Catherine, Vickerman, Peter, Rees, Helen, Watts, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875434/
https://www.ncbi.nlm.nih.gov/pubmed/24386160
http://dx.doi.org/10.1371/journal.pone.0083193
_version_ 1782297349671878656
author Terris-Prestholt, Fern
Hanson, Kara
MacPhail, Catherine
Vickerman, Peter
Rees, Helen
Watts, Charlotte
author_facet Terris-Prestholt, Fern
Hanson, Kara
MacPhail, Catherine
Vickerman, Peter
Rees, Helen
Watts, Charlotte
author_sort Terris-Prestholt, Fern
collection PubMed
description BACKGROUND: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experiment (DCE) to: understand the relative strength of women’s preferences for product characteristics, understand the implications for substitution away from male condoms, and inform realistic modelling of their potential impact and cost-effectiveness. METHODS: A DCE was conducted among 1017 women in urban South Africa. Women were presented with choices between potential women’s NPTs (microbicides, diaphragm, female condom) and ‘what I did last time’ (use or not use a condom) with different HIV and pregnancy prevention effectiveness’ and prices. Choice probabilities are estimated using the nested logit model and used to predict uptake. RESULTS: In this high HIV prevalence setting, HIV prevention effectiveness is the main driver of uptake followed by pregnancy prevention effectiveness. For example a microbicide with poor effectiveness would have niche appeal at just 11% predicted uptake, while a highly effective microbicide (95% effective against HIV and pregnancy) would have far wider appeal (56% predicted uptake). Though women who reported not using condoms were more likely to choose the NPTs, at current very high rates of male condom use in South Africa (60%), about half of microbicide uptake is projected to be among those currently not using condoms. CONCLUSIONS: Women are very interested in NPTs, especially if highly effective in preventing HIV and pregnancy. Women in greatest need were also most likely to switch to the new products. Where products are not yet available for distribution, proxy data, such as that generated by DCEs, can bring realism to overly optimistic uptake scenarios found in many current impact models.
format Online
Article
Text
id pubmed-3875434
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38754342014-01-02 How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa Terris-Prestholt, Fern Hanson, Kara MacPhail, Catherine Vickerman, Peter Rees, Helen Watts, Charlotte PLoS One Research Article BACKGROUND: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experiment (DCE) to: understand the relative strength of women’s preferences for product characteristics, understand the implications for substitution away from male condoms, and inform realistic modelling of their potential impact and cost-effectiveness. METHODS: A DCE was conducted among 1017 women in urban South Africa. Women were presented with choices between potential women’s NPTs (microbicides, diaphragm, female condom) and ‘what I did last time’ (use or not use a condom) with different HIV and pregnancy prevention effectiveness’ and prices. Choice probabilities are estimated using the nested logit model and used to predict uptake. RESULTS: In this high HIV prevalence setting, HIV prevention effectiveness is the main driver of uptake followed by pregnancy prevention effectiveness. For example a microbicide with poor effectiveness would have niche appeal at just 11% predicted uptake, while a highly effective microbicide (95% effective against HIV and pregnancy) would have far wider appeal (56% predicted uptake). Though women who reported not using condoms were more likely to choose the NPTs, at current very high rates of male condom use in South Africa (60%), about half of microbicide uptake is projected to be among those currently not using condoms. CONCLUSIONS: Women are very interested in NPTs, especially if highly effective in preventing HIV and pregnancy. Women in greatest need were also most likely to switch to the new products. Where products are not yet available for distribution, proxy data, such as that generated by DCEs, can bring realism to overly optimistic uptake scenarios found in many current impact models. Public Library of Science 2013-12-30 /pmc/articles/PMC3875434/ /pubmed/24386160 http://dx.doi.org/10.1371/journal.pone.0083193 Text en © 2013 Terris-Prestholt et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Terris-Prestholt, Fern
Hanson, Kara
MacPhail, Catherine
Vickerman, Peter
Rees, Helen
Watts, Charlotte
How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
title How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
title_full How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
title_fullStr How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
title_full_unstemmed How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
title_short How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
title_sort how much demand for new hiv prevention technologies can we really expect? results from a discrete choice experiment in south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875434/
https://www.ncbi.nlm.nih.gov/pubmed/24386160
http://dx.doi.org/10.1371/journal.pone.0083193
work_keys_str_mv AT terrisprestholtfern howmuchdemandfornewhivpreventiontechnologiescanwereallyexpectresultsfromadiscretechoiceexperimentinsouthafrica
AT hansonkara howmuchdemandfornewhivpreventiontechnologiescanwereallyexpectresultsfromadiscretechoiceexperimentinsouthafrica
AT macphailcatherine howmuchdemandfornewhivpreventiontechnologiescanwereallyexpectresultsfromadiscretechoiceexperimentinsouthafrica
AT vickermanpeter howmuchdemandfornewhivpreventiontechnologiescanwereallyexpectresultsfromadiscretechoiceexperimentinsouthafrica
AT reeshelen howmuchdemandfornewhivpreventiontechnologiescanwereallyexpectresultsfromadiscretechoiceexperimentinsouthafrica
AT wattscharlotte howmuchdemandfornewhivpreventiontechnologiescanwereallyexpectresultsfromadiscretechoiceexperimentinsouthafrica